Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strains.

Antimicrobial Agents and Chemotherapy
M TodaS Mitsuhashi

Abstract

N-Formimidoyl thienamycin (MK0787) was active against beta-lactamase-producing strains and was an effective inhibitor of beta-lactamases extracted and purified from these strains except for plasmid-mediated penicillinase type IV.

References

Jan 1, 1976·Antimicrobial Agents and Chemotherapy·Y SawadaS Mitsuhashi
Sep 1, 1977·Journal of Bacteriology·Y Fujii-KuriyamaS Sugawara
Sep 1, 1975·Antimicrobial Agents and Chemotherapy·S YaginumaS Mitsuhashi
Nov 1, 1978·Antimicrobial Agents and Chemotherapy·H C Neu, K P Fu
Apr 1, 1979·Antimicrobial Agents and Chemotherapy·S S WeaverB M LeBlanc
Sep 1, 1978·Antimicrobial Agents and Chemotherapy·F P TallyS L Gorbach
May 1, 1977·Antimicrobial Agents and Chemotherapy·C Reading, M Cole
Jun 1, 1974·The Biochemical Journal·S G Waley
Mar 1, 1974·Japanese Journal of Microbiology·S YaginumaS Mitsuhashi
Jul 1, 1973·Analytical Biochemistry·G W RossC H O'Callaghan
Nov 1, 1970·Journal of Bacteriology·T SawaiS Mitsuhashi

❮ Previous
Next ❯

Citations

Oct 1, 1984·European Journal of Clinical Microbiology·I Braveny
Jun 7, 1985·The American Journal of Medicine·R N Jones
Apr 1, 1982·Antimicrobial Agents and Chemotherapy·F KobayashiS Mitsuhashi
Oct 1, 1982·Antimicrobial Agents and Chemotherapy·Y SainoS Mitsuhashi
Oct 1, 1982·Antimicrobial Agents and Chemotherapy·K SatoS Mitsuhashi
Oct 1, 1982·Antimicrobial Agents and Chemotherapy·H MikamiS Mitsuhashi
Dec 1, 1983·Antimicrobial Agents and Chemotherapy·A YotsujiS Mitsuhashi
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·K SatoS Mitsuhashi
Apr 1, 1988·Antimicrobial Agents and Chemotherapy·S MitsuhashiM Inoue
Nov 6, 2007·Expert Opinion on Emerging Drugs·Malcolm G P Page
Feb 8, 1985·The American Journal of Medicine·J D Allan, R C Moellering
Oct 1, 1983·Medicinal Research Reviews·S J Cartwright, S G Waley
Mar 1, 1987·Drug Intelligence & Clinical Pharmacy·R P RappT S Foster

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.